M&A Deal Summary

Pernix Therapeutics Holdings Acquires Somaxon Pharmaceuticals

On December 11, 2012, Pernix Therapeutics Holdings acquired medical products company Somaxon Pharmaceuticals from Montreux Equity Partners for 25M USD

Acquisition Highlights
  • This is Pernix Therapeutics Holdings’ 2nd transaction in the Medical Products sector.
  • This is Pernix Therapeutics Holdings’ largest (disclosed) transaction.
  • This is Pernix Therapeutics Holdings’ 2nd transaction in the United States.
  • This is Pernix Therapeutics Holdings’ 1st transaction in California.

M&A Deal Summary
Date 2012-12-11
Target Somaxon Pharmaceuticals
Sector Medical Products
Buyer(s) Pernix Therapeutics Holdings
Sellers(s) Montreux Equity Partners
Deal Type Add-on Acquisition
Deal Value 25M USD
Advisor(s) Stifel, Nicolaus & Co., Inc. (Financial)

Target

Somaxon Pharmaceuticals

Solana Beach, California, United States
Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focuses on psychiatric and neurological conditions.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Pernix Therapeutics Holdings

Morristown, New Jersey, United States
Category Company
Founded 1996
Sector Life Science
Employees155
Revenue 176M USD (2015)
DESCRIPTION

Pernix Therapeutics Holdings, Inc. is a pharmaceutical company developing branded and generic pediatric products. Pernix Therapeutics was founded in 1996 and is based in Morristown, New Jersey.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 2 of 2
Year (2012) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-01-02 Cypress Pharmaceuticals

Madison, Mississippi, United States

Cypress Pharmaceuticals manufactures, markets and/or distributes more than 231 drugs in the United States.

Buy -

Seller(S) 1

SELLER

Montreux Equity Partners

Investor Investor

Category Growth Capital Firm
Founded 1993
Size Small
Type Sector Agnostic
DESCRIPTION

Montreux Equity Partners is a growth investment firm focused on investing in commercial stage companies with category leading products, technologies, and services. Montreux Equity Partners looks to invest $10 to $20 million in fast growing companies with $5 to $50 million in revenue. Montreux Equity Partners was formed in 1993 and is headquartered in San Francisco, California.

DEAL STATS #
Overall 17 of 24
Sector (Medical Products) 6 of 10
Type (Add-on Acquisition) 13 of 15
State (California) 16 of 22
Country (United States) 17 of 24
Year (2012) 3 of 3
Size (of disclosed) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-16 SkinMedica

Carlsbad, California, United States

SkinMedica, Inc. is a developing, acquiring and commercializing products that improve the appearance of skin. The Company markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products.

Sell $350M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-22 Tebra

Corona Del Mar, California, United States

Tebra is a provider of cloud-based solutions for independent medical practices. Tebra offers an integrated solution of products and services designed to help physicians get paid faster, find new patients, run their business smarter, and provide better care. Tebra was founded in 2004 and is based in Corona Del Mar, California.

Buy -
Mergr

Product

Company

Legal